Humira $95.6 Billion and Still Going

Quote
Why don't you do it ratso ? FDA would do nothing. Let them play the game and stop drinking hateraid kid cause you arent "gittin" a piece of the action. Seriously though, REPORT IT so Compliance has some easy work and gets off thier lazy ass. Y'all Milieneals are still wet behind the ears and crack at the first minor challenge in life.
 








And BTW kid, make sure you spell ABBVIE correctly. The FDA won't take you seriously if you can't spell the name of the company So you work for "Abbie" ?? Bwaaaa Hah

CASE CLOSED KID
 




Abbvie Humira spots are #1 in National TV ad spending in July with a WHOPPING $32.9 million for one Month
Two each for arthritis and ulcerative colitis/Crohn's and one for psoriasis. Marketing is kicking ass.
 




anonymous said:
Amgens Bio Amgevita is dead in the water in EU for at least a year, and dead in U.S. Until 2020. We hold patent protection in the EU until April 2018 and it will be a long desperately struggle to launch the biosimilars in European markets and they won't succeed any time soon. Rick already stepped on them in U.S. By filing an infringement lawsuit. Out of the $16B in sales only $5B is in EU with $10B in U.S. Don't believe the fake news about this. Amgen didn't have the balls to do at risk launch like they hinted about back in December. NONE of the single switch studies that are being done now would meet the FDA's standard. EVEN If Amgen somehow managed to launch in EU in May 2018, Wall Street consensus for impact on stock would be ONLY $4 decline based on current $66 price Ricks a genius
Click to expand...

Hell yeah ! Rick kept his promise to defend Humira. Promises made promises kept (like trump)! Indeed Amgen got owned by Rick and this year's October launch in Europe will have little impact on ABBV. Amgen won't launch in U.S until JAN 31st 2023 that's a LONG LONG LONG TIME. Plus in the mean time, they'll pay royalties out the wazoo. Sad part is this is just another example of how big pharma exploits the flawed patent system and the weak antitrust enforcement, along with poor drug price regulation to ensure Americans pay out the ass compared to the rest of the world, The devious methods of our industry’s greedy lawyers to circumvent the intent of current regulations is disgusting and we need comprehensive reforms.....But ONLY AFTER I make another $5M. LOL
 












Top Bottom
Back
Quote